Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/40497
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | SANTOS, Gabriel Arantes dos | |
dc.contributor.author | VIANA, Nayara Izabel | |
dc.contributor.author | PIMENTA, Ruan | |
dc.contributor.author | REIS, Sabrina T. | |
dc.contributor.author | LEITE, Katia Ramos Moreira | |
dc.contributor.author | SROUGI, Miguel | |
dc.date.accessioned | 2021-06-17T13:49:37Z | - |
dc.date.available | 2021-06-17T13:49:37Z | - |
dc.date.issued | 2021 | |
dc.identifier.citation | MEDICAL HYPOTHESES, v.150, article ID 110566, 5p, 2021 | |
dc.identifier.issn | 0306-9877 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/40497 | - |
dc.description.abstract | Currently, the biggest challenge for prostate cancer (PCa) is to understand the mechanism by which the disease acquires the castration-resistant phenotype and progresses to a fatal disease. PCa has a high genetic heterogeneity, and cannot be separated into well-defined molecular subtypes. Despite this, there is consensus about the role of the androgen receptor (AR) in all stages of the disease, including the transition to the castration-resistant phenotype. Since AR is a transcription factor, we investigated the possibility of PCa presenting a pattern of global gene expression during disease progression. By analyzing the TCGA and CCLE datasets, we were able to find a pattern of waves of genes being expressed during each stage of disease progression. This phenomenon suggests the existence of a mechanism that globally regulates gene expression, being AR, telomeres, and zinc finger proteins (ZNF), three important players. The AR modulates the telomere biology, and its transcription is regulated by ZNF. Recently, a study suggested that the telomere length might influence the expression of ZNF. Thus, we hypothesized that changes in the triad AR, telomeres, and ZNF control gene expression during the progression of PCa. | eng |
dc.language.iso | eng | |
dc.publisher | CHURCHILL LIVINGSTONE | eng |
dc.relation.ispartof | Medical Hypotheses | |
dc.rights | restrictedAccess | eng |
dc.subject | Gene expression profile | eng |
dc.subject | Castration-resistant prostate cancer | eng |
dc.subject | TCGA | eng |
dc.subject | CCLE | eng |
dc.subject | Zinc finger transcription factor | eng |
dc.subject | Telomere length | eng |
dc.subject | Androgen-signaling axis | eng |
dc.subject.other | dna-content | eng |
dc.subject.other | adenocarcinoma | eng |
dc.subject.other | association | eng |
dc.subject.other | complex | eng |
dc.subject.other | growth | eng |
dc.title | Hypothesis: The triad androgen receptor, zinc finger proteins and telomeres modulates the global gene expression pattern during prostate cancer progression | eng |
dc.type | article | eng |
dc.rights.holder | Copyright CHURCHILL LIVINGSTONE | eng |
dc.identifier.doi | 10.1016/j.mehy.2021.110566 | |
dc.identifier.pmid | 33799157 | |
dc.subject.wos | Medicine, Research & Experimental | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
hcfmusp.description.articlenumber | 110566 | |
hcfmusp.description.volume | 150 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.id | WOS:000641583400017 | |
hcfmusp.origem.id | 2-s2.0-85105005750 | |
hcfmusp.publisher.city | EDINBURGH | eng |
hcfmusp.publisher.country | SCOTLAND | eng |
hcfmusp.relation.reference | Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025 | eng |
hcfmusp.relation.reference | Abildgaard MO, 2012, INT J CANCER, V130, P885, DOI 10.1002/ijc.26097 | eng |
hcfmusp.relation.reference | Aviv A, 2003, MECH AGEING DEV, V124, P829, DOI 10.1016/S0047-6374(03)00143-X | eng |
hcfmusp.relation.reference | Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003 | eng |
hcfmusp.relation.reference | Baydar DE, 2010, PATHOL RES PRACT, V206, P700, DOI 10.1016/j.prp.2010.05.009 | eng |
hcfmusp.relation.reference | Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370 | eng |
hcfmusp.relation.reference | Chang GTG, 2000, J NATL CANCER I, V92, P1414, DOI 10.1093/jnci/92.17.1414 | eng |
hcfmusp.relation.reference | Chen W, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9764752 | eng |
hcfmusp.relation.reference | Cohen PA, 2015, ONCOTARGET, V6, P41566, DOI 10.18632/oncotarget.5893 | eng |
hcfmusp.relation.reference | Culig Z, 2014, CANCER METAST REV, V33, P413, DOI 10.1007/s10555-013-9474-0 | eng |
hcfmusp.relation.reference | Dai C, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a030452 | eng |
hcfmusp.relation.reference | de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005 | eng |
hcfmusp.relation.reference | De Vitis M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020606 | eng |
hcfmusp.relation.reference | Demanelis K, 2020, SCIENCE, V369, P1333, DOI 10.1126/science.aaz6876 | eng |
hcfmusp.relation.reference | Ding CL, 2020, MOL CELL ENDOCRINOL, V506, DOI 10.1016/j.mce.2020.110745 | eng |
hcfmusp.relation.reference | Fordyce CA, 2005, J UROLOGY, V173, P610, DOI 10.1097/01.ju.0000143195.49685.ce | eng |
hcfmusp.relation.reference | Fraser M, 2019, ADV EXP MED BIOL, V1210, P87, DOI 10.1007/978-3-030-32656-2_5 | eng |
hcfmusp.relation.reference | Gao S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078766 | eng |
hcfmusp.relation.reference | Giatromanolaki Alexandra, 2019, Curr Urol, V13, P157, DOI 10.1159/000499276 | eng |
hcfmusp.relation.reference | Graham MK, 2017, NAT REV UROL, V14, P607, DOI 10.1038/nrurol.2017.104 | eng |
hcfmusp.relation.reference | Hay CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139990 | eng |
hcfmusp.relation.reference | Heaphy CM, 2020, HUM PATHOL, V101, P70, DOI 10.1016/j.humpath.2020.04.014 | eng |
hcfmusp.relation.reference | Heaphy CM, 2013, CANCER DISCOV, V3, P1130, DOI 10.1158/2159-8290.CD-13-0135 | eng |
hcfmusp.relation.reference | Jacob S, 2016, CANCER BIOL THER, V17, P439, DOI 10.1080/15384047.2016.1156255 | eng |
hcfmusp.relation.reference | Jen JY, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0269-9 | eng |
hcfmusp.relation.reference | Kim SH, 2010, J BIOL CHEM, V285, P10472, DOI 10.1074/jbc.M109.098798 | eng |
hcfmusp.relation.reference | Kim W, 2018, DIFFERENTIATION, V99, P1, DOI 10.1016/j.diff.2017.11.005 | eng |
hcfmusp.relation.reference | Kirby M, 2011, INT J CLIN PRACT, V65, P1180, DOI 10.1111/j.1742-1241.2011.02799.x | eng |
hcfmusp.relation.reference | Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062 | eng |
hcfmusp.relation.reference | Lin CY, 2018, CANCER SCI, V109, P3564, DOI 10.1111/cas.13776 | eng |
hcfmusp.relation.reference | Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200 | eng |
hcfmusp.relation.reference | Martinez P, 2010, NAT CELL BIOL, V12, P768, DOI 10.1038/ncb2081 | eng |
hcfmusp.relation.reference | Mazzolini R, 2018, NUCLEIC ACIDS RES, V46, P146, DOI 10.1093/nar/gkx958 | eng |
hcfmusp.relation.reference | Meeker AK, 2002, CANCER RES, V62, P6405 | eng |
hcfmusp.relation.reference | Mooney SM, 2015, J CELL BIOCHEM, V116, P115, DOI 10.1002/jcb.24948 | eng |
hcfmusp.relation.reference | Mukherjee AK, 2019, J BIOL CHEM, V294, P17709, DOI 10.1074/jbc.RA119.008687 | eng |
hcfmusp.relation.reference | Mukherjee AK, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007782 | eng |
hcfmusp.relation.reference | Negoita S, 2018, CANCER-AM CANCER SOC, V124, P2801, DOI 10.1002/cncr.31549 | eng |
hcfmusp.relation.reference | Pimenta Ruan Ca, 2018, Tumour Biol, V40, p1010428318803011, DOI 10.1177/1010428318803011 | eng |
hcfmusp.relation.reference | Schalken J, 2016, BJU INT, V117, P215, DOI 10.1111/bju.13123 | eng |
hcfmusp.relation.reference | SICA G, 1994, UROL RES, V22, P33, DOI 10.1007/BF00431546 | eng |
hcfmusp.relation.reference | Sommerfeld HJ, 1996, CANCER RES, V56, P218 | eng |
hcfmusp.relation.reference | Tang ZF, 2019, NUCLEIC ACIDS RES, V47, pW556, DOI 10.1093/nar/gkz430 | eng |
hcfmusp.relation.reference | Tolkach Y, 2018, PATHOBIOLOGY, V85, P108, DOI 10.1159/000477852 | eng |
hcfmusp.relation.reference | Townsley DM, 2016, NEW ENGL J MED, V374, P1922, DOI 10.1056/NEJMoa1515319 | eng |
hcfmusp.relation.reference | Treat EG, 2010, UROLOGY, V75, P724, DOI 10.1016/j.urology.2009.04.032 | eng |
hcfmusp.relation.reference | Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011 | eng |
hcfmusp.relation.reference | Vanaja DK, 2003, CANCER RES, V63, P3877 | eng |
hcfmusp.relation.reference | Vukovic B, 2007, CYTOGENET GENOME RES, V116, P1, DOI 10.1159/000097411 | eng |
hcfmusp.relation.reference | WRIGHT WE, 1992, TRENDS GENET, V8, P193, DOI 10.1016/0168-9525(92)90232-S | eng |
hcfmusp.relation.reference | Wu JC, 2020, MOL CANCER RES, V18, P1326, DOI 10.1158/1541-7786.MCR-19-1129 | eng |
dc.description.index | MEDLINE | eng |
dc.identifier.eissn | 1532-2777 | |
hcfmusp.citation.scopus | 2 | - |
hcfmusp.scopus.lastupdate | 2022-06-30 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MCG Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - LIM/55 Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_SANTOS_Hypothesis_The_triad_androgen_receptor_zinc_finger_proteins_2021.PDF Restricted Access | publishedVersion (English) | 631.95 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.